drugset / Trial / NCT03463915

Clinical Trial Comparing Two Bladder Instillations for IC/BPS

NCT03463915

Phase 3 Completed 90 enrolled Olivia Cardenas-Trowers, M.D.
RandomizedParallel-groupDouble-blindTreatment

Summary

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a condition that results in long-term bladder and pelvic pain. IC/BPS affects women more often than men. How the disorder develops is not completely known. Bladder instillation is a commonly used treatment in which a mixture of different ingredients are passed into the bladder to help IC/BPS symptoms. There is room to learn more about bladder instillations and which ingredients in them work best. The purpose of this study is to compare the effectiveness of a bladder instillation that contains a steroid (triamcinolone acetonide) to a bladder instillation that does not contain a steroid to treat IC/BPS in women. The study hypothesis is that women with IC/BPS treated with bladder instillations that contain a steroid will have improved outcomes compared to women treated with bladder instillations that do not contain a steroid.

Timeline

Start
2019-01-25
Primary completion
2020-10-23
Completion
2020-10-23

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 40 mg Other
Comparator Bupivacaine Other / unclassified 50 mg Other
Comparator Heparin Other / unclassified 10000 iu Other
Comparator Lidocaine Other / unclassified 10 ml Other
Comparator sodium bicarbonate Diagnostic / imaging agent 15 meq Other

Indications